Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts (original) (raw)
- Original Paper
- Published: 17 April 1997
- Antonino Neri1,
- Catarina Cappellini1,
- Federica Cavallo2,
- Mauro Pomati1,
- Chih-Chao Chang3,
- Anna Teresa Maiolo1 &
- …
- Luigia Lombardi1
Oncogene volume 14, pages 1805–1810 (1997)Cite this article
- 380 Accesses
- 42 Citations
- Metrics details
Abstract
The NFKB-2 (Lyt-10) gene codes for an NF-κB-related transcription factor containing rel-polyG-ankyrin domains. Rearrangements of the NFKB-2 locus leading to the production of 3′ truncated NFKB-2 proteins are recurrently found in lymphoid neoplasms, particularly cutaneous lymphomas. Such mutant NFKB-2 proteins have lost the ability to repress transcription that is typical of NFKB-2 subunit p52, and function as constitutive transcriptional activators. To verify whether the expression of abnormal NFKB-2 proteins can lead to malignant transformations in mammalian cells, we transfected human lymphoblastoid cell lines and murine fibroblasts (Balb/3T3) with expression vectors carrying the cDNAs coding for normal NFKB-2p52, Lyt-10Cα or LB40 proteins, which are representative of the abnormal types found in lymphoma cases. The expression of both normal and mutant NFKB-2 proteins has a lethal effect on lymphoblastoid cells and a cytotoxic effect was also observed in murine fibroblasts. The fibroblast cell lines expressing Lyt-10Cα or LB40, but not those expressing normal NFKB-2p52, were capable of forming colonies in soft agar. The analysis of individual clones revealed that cloning efficiency correlated with the expression levels of the abnormal proteins. Injection of the Lyt-10Cα-transfected Balb cells in SCID mice led to tumor formation in all of the animals, whereas no tumors were observed in the mice injected with control or NFKB-2p52-transfected cells, thus indicating that abnormal NFKB-2 protein expression is tumorigenic in vivo. Our results show that mutant NFKB-2 proteins can lead to the transformed phenotype, and support the hypothesis that alterations in NFKB-2 genes may play a role in lymphomagenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Laboratorio di Ematologia Sperimentale e Genetica Molecolare, Servizio di Ematologia, Istituto di Scienze Mediche, Università di Milano, Ospedale Maggiore IRCCS Milan, Italy
Paolo Ciana, Antonino Neri, Catarina Cappellini, Mauro Pomati, Anna Teresa Maiolo & Luigia Lombardi - Dipartimento di Scienze Cliniche Biologiche, Università di Torino, Turin, Italy
Federica Cavallo - Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, USA
Chih-Chao Chang
Authors
- Paolo Ciana
You can also search for this author inPubMed Google Scholar - Antonino Neri
You can also search for this author inPubMed Google Scholar - Catarina Cappellini
You can also search for this author inPubMed Google Scholar - Federica Cavallo
You can also search for this author inPubMed Google Scholar - Mauro Pomati
You can also search for this author inPubMed Google Scholar - Chih-Chao Chang
You can also search for this author inPubMed Google Scholar - Anna Teresa Maiolo
You can also search for this author inPubMed Google Scholar - Luigia Lombardi
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Ciana, P., Neri, A., Cappellini, C. et al. Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts.Oncogene 14, 1805–1810 (1997). https://doi.org/10.1038/sj.onc.1201015
- Received: 30 July 1996
- Revised: 07 January 1997
- Accepted: 07 January 1997
- Issue Date: 17 April 1997
- DOI: https://doi.org/10.1038/sj.onc.1201015